Fig. 1 · Structure
Documents & Downloads
Cinromide
Anticonvulsant Agent
Cinromide is an anticonvulsant agent that functions by inhibiting the epithelial neutral amino acid transporter B0AT1 (SLC6A19), with an IC50 value of 0.5 μM. This inhibition is significant for studying transport-related disorders and may have implications in neurological research. Cinromide's effect on amino acid transport makes it a valuable tool for investigating the role of neurotransmitter modulation in seizures and other related conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 58473-74-8 |
| Applications | Anticonvulsant Agent |
| Formula | C11H12BrNO |
| Molecular Weight | 254.12 |
| Synonyms | trans-3-Bromo-N-ethylcinnamamide |
| SMILES | O=C(NCC)/C=C/C1=CC=CC(Br)=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.